Moderna Inc said the US Centers for Disease Control and Prevention's (CDC) Advisory Committee on Immunisation Practices voted to recommend the use of the company's COVID-19 vaccine on people 18 years of age and older.
The panel voted 11-0 in favour of the vaccine, the company said in a press release.
The vote result came a day after the Food and Drug Administration's authorisation for emergency use of Moderna's COVID-19 vaccine.
"ACIP recommendation is another step forward in our quest to address this devastating pandemic with a vaccine," Chief Executive Officer Stephane Bancel said in the release.
Moderna's is the second COVID-19 vaccine to receive approval in the United States after a similar vaccine from Pfizer Inc and German partner BioNTech SE got the green light for emergency use.
US distribution of Moderna's vaccine began on Saturday, with more than 3,700 sites due to start receiving and administering shots as soon as Monday.
Turkey sentences 11 people to life in prison over ski resort hotel fire
Israel launches more strikes on Gaza overnight, testing fragile truce
Trump-Putin summit cancelled, FT reports
Houthis say 43 detained UN staff to face trial over Israeli attack
Hurricane Melissa leaves 49 dead in Caribbean, churns north
King Charles strips brother Andrew of titles and his mansion
Vietnam flood death toll rises to 13, with 11 others missing
US grants India six-month sanctions waiver to run Iran's Chabahar port
